Silbereisen A, Hallak A K, Nascimento G G, Sorsa T, Belibasakis G N, Lopez R, Bostanci N
Section of Periodontology and Dental Prevention, Division of Oral Diseases of Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
Section of Periodontology, Department of Dentistry and Oral Health, Aarhus University, Aarhus, Denmark.
JDR Clin Trans Res. 2019 Oct;4(4):352-359. doi: 10.1177/2380084419844937. Epub 2019 Apr 23.
The triggering receptor expressed on myeloid cells 1 (TREM-1) signaling pathway is stimulated by bacteria and, together with its putative ligand peptidoglycan recognition protein 1 (PGLYRP1), propagates proinflammatory responses.
We aimed to evaluate the TREM-1/PGLYRP1/interleukin (IL)-1β regulation in response to biofilm accumulation and removal in an experimental human gingivitis model.
The study (n = 42 participants, mean age: 23.8 ± 3.7 y) comprised a recruitment step (day -14) followed by experimentally induced biofilm formation (induction [I] phase, day 0 to +21) and a 2-wk resolution (R) phase (day +21 to +35). Plaque was recorded by the Modified Quigley and Hein Plaque Index (TQHPI), while records of gingival inflammation were based on the Modified Gingival Index (MGI). Unstimulated whole saliva supernatants (n = 210, 5 time points) were tested for TREM-1, PGLYRP1, and IL-1β by enzyme-linked immunosorbent assay.
During the I-phase, concentrations of all analytes showed a tendency for downregulation at day +7 compared to day 0. TREM-1 (P = 0.019) and PGLYRP1 (P = 0.007) increased significantly between day +7 and day +21. Although all analyte levels decreased during the R-phase, the difference was not significant except TREM-1 being at borderline significance (P = 0.058). Moreover, TREM-1, PGLYRP1, and IL-1β showed significant positive correlations (P < 0.0001) with each other. The study participants were grouped into "fast" and "slow" responders based on clinical gingival inflammation scores. At each time point, fast responders showed significantly higher concentrations of TREM-1 (P < 0.025), PGLYRP1 (P < 0.007), and IL-1β (P < 0.025) compared to slow responders. Mixed-effects multilevel regression analyses revealed that PGLYRP1 (P = 0.047) and IL-1β (P = 0.005) showed a significant positive association with the MGI scores.
The study demonstrated that TREM-1 and PGLYRP1 are regulated in response to biofilm accumulation and removal, and fast responders demonstrated higher levels of these analytes compared to slow responders.
The results of this study demonstrated the suitability of salivary TREM-1 and PGLYRP1 to reflect biofilm accumulation and removal and PGLYRP1 to monitor the progression and resolution of inflammation in gingivitis-susceptible individuals (fast responders). Combined with conventional risk factors, the molecular toolbox proposed here should be further validated in future studies to confirm whether it can be used for population-based monitoring and prevention of gingivitis.
髓样细胞表达的触发受体1(TREM-1)信号通路受细菌刺激,并与其假定配体肽聚糖识别蛋白1(PGLYRP1)一起传播促炎反应。
我们旨在评估在实验性人类牙龈炎模型中,响应生物膜积聚和清除时TREM-1/PGLYRP1/白细胞介素(IL)-1β的调节情况。
该研究(n = 42名参与者,平均年龄:23.8±3.7岁)包括一个招募阶段(第-14天),随后是实验性诱导生物膜形成(诱导[I]阶段,第0天至+21天)和一个为期2周的消退(R)阶段(第+21天至+35天)。通过改良的奎格利和海因菌斑指数(TQHPI)记录菌斑,而牙龈炎症记录基于改良牙龈指数(MGI)。通过酶联免疫吸附测定法检测未刺激的全唾液上清液(n = 210,5个时间点)中的TREM-1、PGLYRP1和IL-1β。
在I阶段,与第0天相比,所有分析物的浓度在第+7天显示出下调趋势。TREM-1(P = 0.019)和PGLYRP1(P = 0.007)在第+7天至第+21天之间显著增加。尽管所有分析物水平在R阶段均下降,但除TREM-1处于临界显著水平(P = 0.058)外,差异均不显著。此外,TREM-1、PGLYRP1和IL-1β相互之间显示出显著的正相关(P < 0.0001)。根据临床牙龈炎症评分,研究参与者被分为“快速”和“缓慢”反应者。在每个时间点,与缓慢反应者相比,快速反应者的TREM-1(P < 0.025)、PGLYRP1(P < 0.007)和IL-1β(P < 0.025)浓度显著更高。混合效应多级回归分析显示,PGLYRP1(P = 0.047)和IL-1β(P = 0.005)与MGI评分呈显著正相关。
该研究表明,TREM-1和PGLYRP1受生物膜积聚和清除的调节,与缓慢反应者相比,快速反应者的这些分析物水平更高。
本研究结果表明,唾液TREM-1和PGLYRP1适用于反映生物膜的积聚和清除,PGLYRP1适用于监测牙龈炎易感个体(快速反应者)炎症的进展和消退。结合传统风险因素,这里提出的分子工具箱应在未来研究中进一步验证,以确认其是否可用于基于人群的牙龈炎监测和预防。